Back to Results
First PageMeta Content
Warfarin / Chemistry / Nomogram / CYP2C9 / Vitamin K epoxide reductase / Ketones / Rodenticides / Teratogens


Clinical Application of a K-PD Warfarin Model for Bayesian Dose Individualisation in Primary Care D. F. B. Wright, S. B. Duffull[removed]
Add to Reading List

Document Date: 2014-05-13 02:29:07

Open Document

File Size: 746,96 KB

Share Result on Facebook

City

Genotype / Bayesian / Brisbane / Qld / /

Company

Macmillan Publishers Ltd / Model Answers Pty Ltd. / DoseMe Pty Ltd. / adapted using DoseMe / /

Country

Australia / /

Currency

USD / INR / /

/

Event

FDA Phase / /

Facility

University of Queensland / /

IndustryTerm

au Web / dosing solution / /

MedicalCondition

non-valvular atrial fibrillation / MS / /

MedicalTreatment

medication errors / /

Organization

School of Medicine / University of Queensland / Brisbane / National Science Foundation / United Nations / /

Person

Van Spall / /

Position

Author / Governor / representative / /

Product

CROWN / vitamin K / EC50 / C2m / /

ProvinceOrState

Queensland / /

Technology

pharmacokinetics / Simulation / genotype / /

URL

http /

SocialTag